In conclusion, we should consider the possibility of MD in patients with young to middle-aged onset, thin or normal body size, hearing loss, family history of maternal-inherited diabetes or hearing loss, negative antibodies (IAA, ICA, GAD), and residual islet cell function after a long course of disease. This evidence concerns the gene GAD1 and Menkes disease.